Wolf-Meinhard Becker

Title: Wolf-Meinhard Becker: Innovator in Allergen Immunotherapy

Introduction

Wolf-Meinhard Becker is a notable inventor based in Darmstadt, Germany. He has made significant contributions to the field of allergen immunotherapy, particularly through his innovative approaches to modifying allergens for therapeutic use. His work focuses on improving the efficacy and safety of allergy treatments.

Latest Patents

Wolf-Meinhard Becker holds a patent for "Graminae pollen allergen mutants for specific immunotherapy, and production and use of the same." This invention relates to modified recombinant allergen mutants derived from natural raw materials, such as pollen from specific grass species. These modified allergens stimulate lymphocytes from allergic patients to proliferate and synthesize cytokines while exhibiting a significantly reduced ability to bind to IgE antibodies present in the serum of T lymphocyte donors. This characteristic allows for a more targeted and effective allergy therapy.

Career Highlights

Becker is associated with Merck Patent Gesellschaft MIT, where he has been instrumental in advancing research and development in allergen immunotherapy. His innovative work has positioned him as a key figure in the field, contributing to the understanding and treatment of pollen allergies.

Collaborations

Throughout his career, Wolf-Meinhard Becker has collaborated with esteemed colleagues, including Helga Kahlert and Hans-Thomas Stüwe. These collaborations have further enriched his research and expanded the impact of his inventions in the field of immunotherapy.

Conclusion

Wolf-Meinhard Becker's contributions to allergen immunotherapy through his innovative patent demonstrate his commitment to improving allergy treatments. His work continues to influence the field and offers hope for more effective therapies for allergy sufferers.